Cargando…
The Clinical Impact of Seropositivity on Treatment Response in Patients with Rheumatoid Arthritis Treated with Etanercept: A Real-World Iraqi Experience
PURPOSE: To assess the clinical impact of rheumatoid factor (RF) and anti-cyclic citrullinated peptide antibody (ACPA)’s seropositivity on treatment response in patients with rheumatoid arthritis (RA) treated with etanercept. PATIENTS AND METHODS: A retrospective analysis of patients with RA registe...
Autores principales: | Ridha, Asal, Hussein, Saba, AlJabban, Ali, Gunay, Levent Mert, Gorial, Faiq I, Al Ani, Nizar Abdulateef |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9215842/ https://www.ncbi.nlm.nih.gov/pubmed/35756976 http://dx.doi.org/10.2147/OARRR.S368190 |
Ejemplares similares
-
Clinical Outcomes in Iraqi Patients with Rheumatoid Arthritis Following Earlier or Later Treatment with Etanercept
por: Al-Ani, Nizar, et al.
Publicado: (2021) -
Long-Term Adherence to Etanercept in Treatment Effectiveness of Patients with Spondyloarthritis: 7-Year Data from the Iraq National Registry
por: Younis, Ali Abdulrahman, et al.
Publicado: (2022) -
Challenges in Applying Treat to Target Strategy in Sample of Iraqi Patients with Rheumatoid Arthritis
por: Jassim, Nizar Abdulateef, et al.
Publicado: (2021) -
Association of tumor necrosis factor-alpha promoter region gene polymorphism at positions -308G/A, -857C/T, and -863C/A with etanercept response in Iraqi rheumatoid arthritis patients
por: Mohammed, Samer, et al.
Publicado: (2022) -
The adjuvant use of calcium fructoborate and borax with etanercept in patients with rheumatoid arthritis: Pilot study
por: Hussain, Saad Abdulrahman, et al.
Publicado: (2016)